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Background: Epidemiological studies about cardiovascular diseases often rely on methods based on time-to-first-event
for data analysis. Without taking into account multiple event-types and the recurrency of a specific cardiovascular event,
this approach may underestimate the overall cardiovascular burden of some risk factors, if that is the goal of the study.
Methods: In this study we compare four different statistical approaches, all based on the Weibull distribution family of
survival model, in analyzing cardiovascular risk factors. We use data from the Cardiovascular Health Study as illustration.
The four models respectively are time-to-first-event only, recurrent-events only, multiple-event-types only, and joint
recurrent and multiple-event-type models.
Results: Although the four models produce consistent results regarding the significance of the risk factors, the
magnitude of the hazard ratios and their confidence intervals are different. The joint model produces hazard ratios that
are substantially higher than the time-to-first-event model especially for the risk factors of smoking and diabetes.
Conclusion: Our findings suggest that for people with diabetes and are currently smoking, the overall cardiovascular
burden of these risk factors would be substantially higher than that estimated using time-to-first-event method.
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Smoking, diabetes, blood pressure, and serum choles-
terol have long been associated with cardiovascular dis-
ease (CVD); they are considered standard risk factors
and used in prediction models such as the Framingham
Risk Score [1,2]. Risk prediction scores have been de-
rived from prospective cohort studies which typically
utilize a time-to-first event/proportional hazards model
approach to investigate associations between risk factors
and outcomes [3-6]. If multiple events are ascertained,
for example a revascularization, myocardial infarction, a
stroke, and heart failure, only one is represented in the
analysis. However it is this constellation of cardiovascu-
lar events, not the one first recorded, that reflects the
genuine CVD burden faced by an individual. Adding to
the complexity is recurrent events of the same type, if* Correspondence: eip@wakehealth.edu
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unless otherwise stated.the first event is survived. Recurrent events clearly nega-
tively impact cardiovascular health but are ignored in
time-to-first-event analysis.
One naïve way to include both multiple event types and
recurrent events is to treat individual events, regardless of
event-type and first or recurrent status, as statistically in-
dependent. Although this approach circumvents the need
for advanced methods and could easily use standard sur-
vival analysis techniques, the naïve method produces
biases in both the point estimate and the associated stand-
ard error. The standard error is deflated because of the ap-
parent increase in the number of observations as a result
of including multiple event types and recurring occur-
rences; this would tend to produce smaller p-values and
overly optimistic results. While proper analytic tools that
take into account both multiple event-type burdens and
recurrency are available, there is little literature about
comparing the different methods and their respective find-
ings regarding the assessment of risk factors on overall
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cially as extensions to the Cox proportional hazard ap-
proach. Starting perhaps with a foundational paper by
Anderson and Gill, [7], the literature for recurrent data
includes the marginal model [8], total time and gap-time
models [9,10], random effects/frailty models [11], and a
counting process approach [12]. Discussions of the dif-
ferent approaches for recurrent models can be found in
other articles [13,14]. Empirical comparison between dif-
ferent recurrent models suggested that results derived
from different models could be substantially different,
and the optimal model could depend on the context
[15]. Models for multiple end-points in survival analysis
include the bivariate survival model [16], the marginal
model [8], and random effects/frailty models [17]. See
Hougaard, [18] for a general overview. Detailed explan-
ation of recurrent and multiple end-points survival
models can be found in textbook such as [19].
This study aims to compare traditional time-to-first-
event model with approaches that take into account
multiple cardiovascular burden and/or recurrency in
the context of a prospective cohort study- the Cardio-
vascular Health Study (CHS). In order to provide direct
comparison of the methods and derive a real-world esti-
mate of the extent of understated cardiovascular risk by
using time-to-first-event approaches, we selected to use
a class of parametric survival models that is amenable
to different approaches and then applied the various ap-
proaches to a single significant epidemiologic data set –
the CHS. The selected parametric survival approaches
for recurrent and multiple event-types relied heavily on
random effects models. As a result, the direct effects es-
timated using different approaches cannot be immedi-
ately compared. The fixed effect for smoking, in the
random effect model, for example, represents an esti-
mate that is conditional on the random effect. One way
to solve the problem is to “marginalize” the mixed ef-
fects models – i.e., first estimate the mixed effects
model and then integrate out the random effects based
on the estimated parameters from the previous step
[20,21]. To summarize, instead of proposing new epide-
miologic methods for multiple event-types and recur-
rent events, our goal here is two-folded: (1) to present
results from applying comparable models representing
different approaches for handling time-to-event data,
and (2) to assess the level of discrepancies in traditional
risk reporting on a collection of well-known cardiovas-
cular risk factors of their effects on overall cardiovascu-
lar burden.
Methods
CHS is a prospective population-based cohort study begun
in 1989 of risk factors for coronary heart disease (CHD)
and stroke in adults 65 years and older; details regardingthe sampling strategy and data collection have been pub-
lished [22,23]. By June 1990, four Field Centers com-
pleted the recruitment of 5,201 participants. Between
November 1992 and June 1993, an additional 687 African
Americans were recruited using similar methods. The
Field Centers are located in Forsyth County, NC;
Sacramento County, CA; Washington County, MD;
and Pittsburgh, PA. The baseline examinations con-
sisted of a home interview and a clinic examination that
assessed traditional risk factors. Until 1999, semi-
annual contacts alternated between clinic examinations
and telephone contacts, during which information
about hospitalizations and potential CVD events was
collected.
The identification and adjudication of incident events
followed a standard protocol. CHS collected hospital
records (discharge summaries and appropriate lab/im-
aging records) for all hospitalizations that were identi-
fied by clinic staff via follow-up phone calls and visits.
A panel of physician adjudicators then reviewed clinical
information for the first of any specific type of events.
Initial and subsequent events were identified in the
same way and records obtained for all potential events
when available, but for subsequent events, because of
budget constraints, these records were not sent to the
physician panel to verify what the clinics had found. By
comparing ICD9 codes from discharge summaries vs.
adjudicated endpoint, it was reported that specificity
was high (e.g., for myocardial infarction it was 97%),
but sensitivity was lower (81%) [21]. Thus, potential
endpoints might be missed, but if events were reported
via ICD9 it was unlikely that they were misclassified.
The adjudicated events are myocardial infarction, an-
gina, heart failure, stroke, transient ischemic attack,
coronary revascularization (angioplasty or bypass sur-
gery), claudication, and CHD and non-CHD mortality.
In summary, for each event type, only the first event
was adjudicated. Events which occurred prior to July 1,
2002 were available for analysis (hence a range of
follow-up from 8–13 years for the original and supple-
mental cohorts).
For all analyses we utilized a de-identified, public-use
data set obtained from BIOLINC after IRB approval.
The CHS public-use dataset differs from the original
dataset in that age is only reported in 2-year bands,
and extreme values of continuous variables are trun-
cated to prevent identification of individuals. The use
of CHS data was approved by the Institution Review
Board of Wake Forest University Health Sciences. The
CHS study obtained informed consent from each par-
ticipant and IRB approvals were obtained from each of
the four field sites at Wake Forest University Health
Sciences, University of California at Davis, Johns
Hopkins University, and the Univeristy of Pittsburg.
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The statistical models that we considered include the
time-to-first-event survival model, the recurrent event
survival model for a single event-type, the multivariate
survival model for different event-types, and the multivari-
ate recurrent survival model which takes into account
both event-type and recurrent events. For all models, we
included as covariates traditional risk factors for CVD
(age, systolic blood pressure, use of anti-hypertensive
drugs, total and HDL cholesterol, diabetes, smoking -
former and current- and family history), as well as body
weight categories (normal, overweight, obesity), baseline
CVD history, gender, race (White, African American,
other) education level, and use of lipid lowering drugs. For
direct comparison, all 4 models have similar set ups and
are all based on the Weibull hazard model. The Weibull
model is a widely used parametric survival model and it
posits that the hazard function follows the Weibull distri-
bution, which is characterized by two parameters- the
scale parameter λ(> 0) and the shape parameter ρ(> 0).
The scale parameter is reparameterized with regression
coefficients. Specifically, the density function of the Wei-
bull distribution can be expressed as follows:
f yð Þ ¼ λρyρ−1e−λyρ ; ð1Þ
where y(≥0) denote the variable of interest, which in
our case is the time to event. When the shape parameter
ρ = 1, the Weibull model reduces to the exponential
model, implying that the hazard is a constant over time.
When ρ < 1(ρ > 1) the hazard decreases (increases) with
time. This flexibility is important because the risk for
cardiovascular event in CVD patients is unlikely to re-
main constant over time. Furthermore, the mean and
variance from a Weibull model can be directly computed
from the two parameters in closed form, making interpret-
ation straightforward. The specifics of the four survival
models, which are based on the Weibull distribution in
equation (1), are described as follows. In all cases, we as-
sume that participants are statistically independent en-
tities. Additionally, for comparability purpose, we used
baseline values of the covariates in all four models.
Model 1: Time-to-first-event survival model
The scale parameter in equation (1) is assumed to be a
function of a vector of covariates x. To enforce the posi-
tivity of the scale parameter, it is standard to employ the
exponential function such that
λ ¼ exp β0 þ βTx
 
; ð2Þ
where β0 is an intercept term, and β is a vector of coef-
ficients. To fully describe the model, we denote the time-
to-first-event (any event-type) and covariate features forindividual i respectively by yi and xi. Therefore, Model 1 is
specified by the equation:
f yi xiÞ ¼ ρyiρ−1 exp β0 þ βTxi
 
exp − exp β0 þ βTxi
 
yi
ρ
 
:

ð3Þ
Model 2: Recurrent-event survival model
This model takes into account the recurrent events but
does not distinguish between event types. In order to
capture the correlation between recurrent events within
the same individual, a common random effect is added
to the regression model for observations from the same
individual. We denote the time to event j, j = 1,⋯, ni,
within individual i, i = 1,⋯,N, by yij such that Model 2
is specified by the following equation:
f

yij
xiÞ ¼ ρyijρ−1 exp β0 þ βTxi þ ai
 
exp

− exp β0 þ βTxi þ ai
 
yij
ρ

;
ð4Þ
where ai denotes the random effect that is common to
recurrent events within the same individual. The ran-
dom effects ai are assumed to follow a normal distribu-
tion of mean 0 and variance σ2.
Model 3. Multivariate event-type survival model
This model is similar to Model 1 except that different
event types are distinguished. In other words, a partici-
pant who has an event of stroke at day 10, then another
event of stroke at day 100 and then an event of angina
at day 150 would be counted as encountering two differ-
ent types of events respectively at day 10 and day 150.
We used a different baseline hazard function for each
event-type and include a random effect for all event
types that an individual experiences. Denoting the time
to first event-type k, k = 1,⋯, K, by yik, Model 3 is speci-
fied by the following equation:
f

yik
xiÞ ¼ ρkyikρk−1 exp β0 þ βTxi þ bi
 
exp

− exp β0 þ βTxi þ bi
 
yik
ρk

;
ð5Þ
where bi denotes the random effect that is common to
different event types the same individual experiences.
The baseline hazard, here characterized by the shape
parameter ρk is assumed to be event-type specific. Simi-
lar to Model 2, the random effects bi are assumed to fol-
low a normal distribution of mean 0 and variance τ2.
Table 1 Characteristics of the sample. Descriptive statistic –
mean (SD) or% of all the predictor variables involved
No. % Mean (SD)
Gender
Male 2466 42.6
Female 3329 57.4
Race
White 4855 83.8
African American 901 15.6
Others 39 0.67
Education
Less than high school 1701 29.5
High school or above 4071 70.5
Age group 71-72*
BMI status
Overweight** 1192 20.6
Obese 1762 30.4
Hypertension drug
Use drug 2749 47.5
Not use drug 3040 52.5
Smoking status
Former smoker 2398 41.4
Current smoker 698 12.1
Systolic BP 5784 136.6 (21.9)
Total cholesterol 5739 211.1 (39.3)
HDL 5730 54.2 (15.7)
Diabetes
Yes 946 16.5
No 4786 83.5
Family history of CVD
Yes 1698 32.0
No 4492 76.3
Lipid lowering drug
Yes 311 5.4
No 5478 94.6
Prior CVD
Yes 1303 22.1
No 4492 76.3
*Age is categorized into 13 2-year age groups, starting at age 65 (i.e., ages 65,66
forms the first group), and the last group includes 89 years old and above.
**Overweight is defined as BMI > 27 in males and 25 in females; Obese is
defined as BMI > 29.6 in males or 27.3 in females.
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survival model
This model combines the features in Models 2 and 3 to
form the most comprehensive model for capturing CVD
burden. We denote the time to recurrent event j of
event-type k within individual i by yijk. Model 4 is char-
acterized by the addition of two random effects:
f

yijk
xiÞ ¼ ρkyijkρk−1 exp β0 þ βTxi þ cik þ di
 
exp

− exp β0 þ βTxi þ cik þ di
 
yijk
ρk

;
ð6Þ
where the event-type random effects cik and the indi-
vidual random effects di respectively follow normal dis-
tributions of means 0 and respective variances χ2 and δ2
. Additionally, the individual specific random effect is as-
sumed to be independent of the event-type random
effect.
In this study, we compared hazard ratio estimates, eβ,
and 95% confidence intervals for the hazard ratios of
relevant risk factors and demographic variables across
the 4 models. Because the interpretation of fixed effects
within a mixed effects model (i.e., one that includes both
fixed and random effects) is different from those esti-
mated from a fixed-effects-only model, we computed es-
timates from a marginalized model for Model 2 – 4 [19].
This would allow estimates to be fairly compared across
the different survival models. The analysis was con-
ducted using SAS PROC NLMIXED (SAS Inc. North
Carolina, USA).
Results
The public-use dataset included 5,795 participants.
Table 1 shows descriptive statistics of the sample; of
note, approximately one-fifth had pre-existing CVD
upon enrollment into CHS. Lipid-lowering drug use was
quite uncommon. Over the follow-up period there were
2,920 deaths, corresponding to an annual mortality rate
was of 4.9% (95% CI 4.7-5.1). Table 2 shows the number
of participants and the respective percentage by event-
types. There were a total of 14,349 events in the data
set. When considering all events (including CVD-related
mortality), approximately 31% of the participants had no
events, 27% one event, and 41% had 2 or more events
(range 2–44) in the dataset. Note that data from partici-
pants with no event over the entire study period or died
during the study period were treated as censored obser-
vations in all models.
To summarize the large volume of information gener-
ated from the analysis, we used a graph to visualize the
results. Figure 1 summarizes the hazard ratio estimates
and confidence interval of the risk factors and demo-
graphic variables from the 4 models. The specific valuesof the estimates, confidence limits, and other details
about statistical inference are included as Additional file
1, however the following patterns are seen in Figure 1:
(1) Models 1 and 3 tend to provide overall lower risk es-
timates for risk factors compared to other models, (2)
Table 2 Statistics of multiple event-types in the CHS cohort
Event type Non-fatal Fatal Total Percentage*
No event - - 1,797 12.5
Myocardial infarction (MI) 961 176 1,137 7.9
Angina 2,872 0 2,872 20.0
Stroke 992 183 1,175 8.2
Congestive heart failure (CHF) 2,964 221 3,185 22.2
Claudication 487 0 487 3.4
Transient ischemic attack (TIA) 337 0 337 2.3
Angioplasty 364 0 364 2.5
Coronary artery bypass 356 0 356 2.5
Electrocardiogram MI (silent) 82 0 82 0.6
CHD-related deaths 0 585 585 4.1
Other deaths 0 1,972 1,972 13.7
Total 9,415 3,137 14,349 100
*Percentage is calculated using the total number of events (14,349) as denominator.
Ip et al. BMC Medical Research Methodology  (2015) 15:15 Page 5 of 7Models 2 and 4 provide similar estimates and confidence
limits; both have higher risk estimates and wider confi-
dence intervals than Model 1 and 3, (3) Model 3 provides
estimates that are similar to Model 1 with slightly shorter
confidence intervals, (4) The impacts of using different
models are consistent over the various risk factors. For the
following risk factors, taking both multiple event-types
and recurrent events into account (Model 4) produces no-
ticeably higher hazard ratios than when using the time-to-
first-event model (Model 1). The hazard ratio under
Model 4 is 1.5 (1.2 under Model 1) for male, 1.39 (1.14)Figure 1 Summary of hazard ratios and confidence intervals of risk fa
(time-to-first-event model, single event type); Model 2 (recurrent event mo
recurrent event model). Circles represent hazard ratios. Confidence intervalfor African American; 1.37 (1.12) for HTN drug; 1.93
(1.44) for current smoker; 1.84 (1.36) for having diabetes;
and 1.74 (1.39) for having prior CVD history.
Discussion
Although comparison between time-to-first-event, recur-
rent, and multiple-events models have been separately
conducted in the literature – a recent example being an
sensitivity analysis of recurrence model against time-to-
first-event model [24], the current study, as far as we
know, is the only study that presents a direct comparison
of the 4 models – time-to-first-event, recurrent, multiple
events, and joint model for recurrent and multiple events.
The analyses presented demonstrate that taking into ac-
count multiple event types, as well as recurrent events
using appropriate statistical techniques, alters the esti-
mated risk associated with several important risk factors
for CVD. The difference is substantial especially for fac-
tors such as having diabetes; the hazard ratio when con-
sidering both multiple event-types and recurrent events is
36% higher when only considering time-to-first-event. For
current smokers, the hazard ratio is 34% higher.
The strengths of this work include the use of a well-
characterized prospective cohort study with a long follow-
up period, providing a large number of events to analyze,
and the application of different statistical approaches under
a common class of models to one dataset. One potential
limitation which may affect analyses of recurrent events to
a greater extent than multiple events types is that subse-
quent events of the same type were not verified via thectors. The summary includes the following survival models: Model 1
del); Model 3 (multivariate event-type model); Model 4 (multivariate
s for Model 4 are shown as thicker lines.
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may make some risk estimates not directly comparable to
prior CHS reports.
There are several implications to our findings. First,
time-to-first-event methods tend to substantially under-
estimate overall risk of important CVD burden of factors
such as smoking and diabetes. Using time-to-first-event
methods also tends to underestimate disparities across
demographic background. The CVD burden for African
Americans, for example, is 21% higher (in hazard ratio)
than Whites when both multiple event types and recur-
rences are taken into account. This study also demon-
strates that in long term studies such as the CHS, multiple
event types and recurrent events are not rare at all. In-
deed, in the CHS cohort, 41% had 2 or more events over
the 8–13 years of follow-up. The substantial proportion of
participants that suffered from recurrent and different car-
diovascular event-types is simply too large to be ignored.
We were surprised by the direction of the hazard ratio
for obesity in all four models. It has been documented in
the literature that an overweight body mass index (BMI) is
associated with lower all-cause mortality or cardiovascular
mortality risks in the elderly but not younger adults [25].
The so-called obesity paradox could perhaps partially ex-
plain the seemingly protective effect of overweight/obese,
as suggested by the current analysis. In order to further ver-
ify this finding, we conducted an exploratory analysis using
visualization and descriptive statistics. The exploratory ana-
lysis suggested that BMI almost have no or little effect on
the risk of a cardiovascular event in this population. A sum-
mary graph of the analysis is provided as Additional file 1.
Our findings also suggest that among the two add-
itional considerations – multiple event-types and recur-
rent events – the argument for including the recurrent
component in the model is stronger. When a recurrent
model - such as Model 2 in the current paper - takes
into account all recurrent events, it will capture a sub-
stantial portion of the variance that arises from multiple
occurrences of cardiovascular event, even when the
types of events are not distinguished. It also needs to be
pointed out that different models could serve different
purposes. The comprehensive model (Model 4) aims to
examine long-term and overall CVD burden while
Model 1 is suitable for assessing risk of the first cardio-
vascular event of a specific type. In summary, the recur-
rent and multiple event-type methods described in this
paper may be particularly well suited towards understand-
ing the burden of illness across populations using claims
data or other electronic health record systems, where sur-
veillance for multiple event types and recurrent events
may not impose significantly increased study costs. These
methods may also be useful for cohort studies or clinical
trials where the outcomes may frequently be repeated (e.g.
heart failure hospitalization).The study has limitations. First, we directly apply four
different models to a real data set and assess the discrep-
ancies between the risk estimates. However, we do not
know the “true” model. Thus a limitation of the study is
that there is no simulation experiment to evaluate the val-
idity of the models. However, it is important to point out
the limitation of simulation experiments in such an emu-
lative study - the optimally fitted model would depend on
the choice of the generative model. For example, if Model
4 is used as the generative or true model, then misspeci-
fied models (Models 1–3) are expected to provide biased
estimates. The same can be said about using other models
as generative models. The value of using a significant real
data set is that the analysis could uncover the magnitude
and direction of potential bias if the “ground truth” is that
both recurrent events and multiple event types do contrib-
ute to the overall cardiovascular risk burden of patients.
We contend that other than Model 4, alternative and
more refined models could be developed for multivariate
recurrent survival data. For example, existing multilevel
models [26] can be extended to provide event-specific
parameter estimates of risk factors. In this paper we do
not distinguish between potentially different effects of
risk factors on different event types as our interest is in
assessing overall cardiovascular burden. In a way, the
overall cardiovascular burden analysis is analogous to
analyzing sum scores of symptoms using a symptom
checklist as opposed to analyzing each symptom indi-
vidually. The two approaches serve different purposes
and are both useful for answering different questions.
A second limitation is the use of a parametric family of
distribution, namely the Weibull family, for modeling time-
to-event. While the Weibull distribution is well known for
its flexibility for incorporating increasing, decreasing, and
constant hazard rates, there are other models such as the
semi-parametric Cox proportional hazard model that are
equally flexible, if not more. The main reason we selected
the Weibull family for all models is that we can have a
computationally tractable and common statistical frame-
work for direct comparison across multiple models. Finally,
we need to caution that the reported results are based on a
single, albeit large-scale epidemiologic study, and the find-
ings may not be always generalizable.Conclusion
This comparison study of several different time-to-event
models demonstrates that the model that takes into ac-
count both recurrent events and multiple event types bet-
ter reflects the overall cardiovascular burden of adults in
the US. For people with diabetes and are currently smok-
ing, the overall cardiovascular burden of these risk factors
would be substantially higher than that estimated using
time-to-first-event method.
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